Celltrion Inc. v. Genentech, Inc. > Summary
Court Case Number IPR2017-01230
Filing Date Mar 31, 2017
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesSheridan K. Snedden, Erica A. Franklin, Jacqueline T. Harlow
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 16, 17, 18, 19, 20, 21, 22, 58, 59, 60
Petitioner
Patent Owner
Petitioner Attorneys
7Celltrion
Attorney Name: Susan Krumplitsch
Cooley LLP
Celltrion
Attorney Name: Adam Pivovar
Cooley LLP
Celltrion
Attorney Name: James P. Brogan
Cooley LLP
Celltrion
Attorney Name: Michelle S. Rhyu
Cooley LLP
Celltrion
Attorney Name: Lauren J. Strosnick
Cooley LLP
Celltrion
Attorney Name: Maria Weiand
Cooley LLP
Celltrion
Attorney Name: Michael Andreeff
The University of Texas M.D. Anderson Cancer Center
Patent Owner Attorneys
7Genentech, Inc
Attorney Name: Lauren N. Drake
Irell & Manella LLP
Genentech, Inc
Attorney Name: David I. Gindler
Irell & Manella LLP
Genentech, Inc
Attorney Name: Yite John Lu
Irell & Manella LLP
Genentech, Inc
Attorney Name: Keith A. Orso
Irell & Manella LLP
Genentech, Inc
Attorney Name: Gary N. Frischling
Irell & Manella LLP
Genentech, Inc
Attorney Name: Michael R. Fleming
Irell & Manella LLP
Genentech, Inc
Attorney Name: David P. Schenkein
Genentech, Inc
Related Patents
Doc No | Title | Issue date |
---|---|---|
07682612 | Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody | Mar 23, 2010 |